|
⚲
|
| Keyboard |
| Kwietniak Matthew R
✚
|
|
|---|---|
| CIK # | 0001974519 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001974519] | |
| 4 | [0001974519] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peregrine Pharmaceuticals Inc | |
| Kwietniak Matthew R |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 7,794 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 58,018 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 881 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 77,454 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2025-02-05 | Disposed to issuer | 50,796 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-26 | Sell | 3,225 | $12.22 | 39,410 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-26 | Sell | 10,165 | $12.22 | 124,216 |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 1,893 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 1,005 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2025 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 15,972 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-25 | Option exercise | 29,479 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2025 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 15,972 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2024 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 6,782 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2024 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 6,782 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2023 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 6,725 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2023 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 6,725 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 4,494 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 1,908 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-25 | Option exercise | 9,300 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-10-14 | Sell | 119 | $10.15 | 1,208 |
| showing 20 of 77 most recent transactions | |||||